IntelliCyt to speak on Flow Cytometry at 5th Assay Meeting Sept 20-21, San Diego

Online, June 28, 2010 (Newswire.com) - Victoria Yatsula, Product Manager from IntelliCyt Corporation, will give a presentation on "Multiplexed Cell-Based Screening Assays by High-Throughput Flow Cytometry" at the 5th Assay and Drug Discovery Technologies Conference to be held this year in San Diego, CA Sept. 20-21, 2010 by GTCbio. This presentation will cover innovative, process-efficient and cost-effective screening tools for protein therapeutics that can be applied to antibody and peptide screens, including all stages of a screening cascade, from primary hybridoma or phage display library screens to lead evaluation functional assays. Yatsula will also discuss the use of endogenous versus recombinant screening cell lines, enabling more physiologically relevant therapeutic models.

Also presenting at the Assay and Drug Discovery Technologies are prestigious organizations including Burnham Medical Research Institute, Pfizer, UCSF, AstraZeneca, UCLA, Bristol Myers Squibb, Genentech, National Institute of Advanced Science and Technology, Johnson & Johnson, Nexigen GmbH, University of Pennsylvania, Roche, UCD, Abbott, Merck, Novartis (GNF), and other leaders in the Assay and Drug Discovery Technologies industry.

5th Assay and Drug Discovery Technologies Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, the exchanges of ideas and networking. Professionals in the drug discovery industry and academics to can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output. For more information, visit www.gtcbio.com.